
July 3 (Reuters) - Abbvie Inc ABBV.N:
ABBVIE INC - REPORTS $823 MILLION IPR&D AND MILESTONES EXPENSE FOR Q2 2025 - SEC FILING
ABBVIE INC - EXPENSE IMPACTS Q2 GAAP AND NON-GAAP EPS BY $0.42 - SEC FILING
ABBVIE INC - 2025 ADJUSTED EPS GUIDANCE RANGE IS $11.67 - $11.87 - SEC FILING
ABBVIE INC - Q2 2025 ADJUSTED EPS GUIDANCE RANGE IS $2.84 - $2.88 - SEC FILING
Source text: [ID:n0001551152-25-000034]